SlideShare une entreprise Scribd logo
1  sur  52
Télécharger pour lire hors ligne
Streamlining Process
Monitoring in Cell Culture
Analysis & Spectrometry
Daniel Merriman
Strategic Marketing Manager
Thermo Fisher Scientific
Femi Egbebi, PhD
Senior Global Product Manager
Media Development
Services/Omics Capabilities
Thermo Fisher Scientific
Krzysztof Inglot, PhD
Technical Sales Specialist
Thermo Fisher Scientific
Application and technical experts
present an overview of process
monitoring systems in the biopharma
field.
Streamlining Process
Monitoring in Cell Culture
Analysis & Spectrometry
Krzysztof Inglot, PhD
Streamlining Process Monitoring
with TruBio
SUT Technical Sales Specialist, CEE & Middle East
Proprietary & Confidential | 25-August-2021
3
Quality Scale-Up is Critical
• Time to market
• Manual data entry
What are the challenges?
What is most critical?
• Consistent/predictable product quality
• System validation
• Data integrity
• GMP manufacturing facility regulatory requirements
• Risk mitigation
• Speed to market
• Efficient, traceable data transfer
• Quality of data maintained throughout the
manufacturing process
Proprietary & Confidential | 25-August-2021
4
Industry Challenge
• Integration of existing equipment causing automation islands
• Highly engineered, product-specific PLC based facilities
• Unique and nonstandard data output
Facility flexibility
Mobius CellReady
EMD Millipore
BioBLU
Eppendorf
UniVessel Glass
Sartorius
ez2-Control
Applikon
Allegro STR
Pall
Xcellerex XDR
GE Life Sciences
Xcellerex XDR 10
GE Life Sciences
BIOSTAT STR
Sartorius
HyPerforma S.U.B.
Thermo Fisher Scientific
Mobius Single-Use Bioreactor
EMD Millipore
Proprietary & Confidential | 25-August-2021
5
Our Solution
A highly configurable, open-architecture system from R&D to production
TruBio Software
Research/PD Clinical to production
Proprietary & Confidential | 25-August-2021
6
Our Solution
One consistent solution from R&D to production
Thermo Scientific™
TruBio™ Software
Clinical
Production
TruBio Software
DCS/SCADA consistent data flow
Research &
Process Development
Proprietary & Confidential | 25-August-2021
7
DeltaV Network
Remote Access
Redundant DeltaV Network
Plant LAN
Operator Station Professional Plus Application Station/Historian
Scales, pumps, G3Lab Universal Controller for
Small Scale Vessels
OPC
SERVER
Plant Messenger
OPC compliant third party bioreactor controllers, Analyzers or other devices
G3Pro Universal controller for highest vessel flexibility as single or dual systems
G3Lite controller for one vessel
Terminal Server
DeltaV Controller
Centrifugation
Mixers
Clarification Chromatography
Virus Removal
Ultrafiltration Sterile filtration
Filtration
OPC
OPC
Operator Station PCs or mobile devices with browser (TS)
Proprietary & Confidential | 25-August-2021
8
Introduction to TruBio
9 Proprietary & Confidential | 25-August-2021
• Software application with inbuilt control
strategies specifically for bioprocesses.
• Commercial off the shelf (COTS), FDA 21 CFR
part 11 compliant.
• Easy to plan, modify and implement new
process requirements using the standard
TruBio functions and features.
• Based on Emerson’s DeltaV with easy scale-
up and -down between R&D, PD and
manufacturing.
• TruBio 5.0 requires DeltaV 12.3 or higher
What is TruBio?
Introduction to TruBio
10 Proprietary & Confidential | 25-August-2021
What are Control Strategies
• Control Strategies are a predefined function
which assist the operators achieve their process
requirements.
• TruBio contains the following functions as
standard (e.g.):
• pH Control
• DO (Dissolved Oxygen) Control
• Temperature Control
• Weight Control
• Dosing
• Continuous
• pH Base and pH Acid
• Pump Totals
• Multi Feed Dosing
• The following functions come as standard in
TruBio to assist in easy setup and process
manipulation:
• Calibration of IO and calibration records (e.g. pH,
DO, pumps)
• Save/load files: easy exchanging control
strategies between sites
• Vessel selection – Move from one vessel
independent of size to another.
• Use the same IO tower for running different vessels.
TruBio Functions
TruBio and Vessel Integration
11 Proprietary & Confidential | 25-August-2021
TruBio
12 Proprietary & Confidential | 25-August-2021
TruBio and Vessel Integration
• Seamless integration with other manufacture vessels and rockers e.g.
• Integration with other manufacture equipment e.g..
TruBio
13 Proprietary & Confidential | 25-August-2021
TruBio Third-party interfacing examples
TRUBIO DeltaV system
Eppendorf
Incubators
GE Chrom Skids Parker NFF Skids Parker TFF Skids
Satorius Scales
Hamilton Probes
Various
Manufacture
TCUs
Remote IO
Panels
Profibus Modbus Ethernet IP
Traditional IO
OPC OPC OPC
Modbus
Traditional IO/ Modbus/
Profibus
Standard TruBio – Process Configuration without
Programming
Proprietary & Confidential | 25-August-2021
14
TruBio 5.0 + G3Lab Universal controller ≤ 250L
HyPerforma Glass Bioreactor HyPerforma Rocker
Benchtop Single-Use Bioreactor HyPerforma SUB
Proprietary & Confidential | 25-August-2021
15
Customized TruBio – Mapping the Process
Proprietary & Confidential | 25-August-2021
16
Customized TruBio – Mapping the Process
Proprietary & Confidential | 25-August-2021
17
Facilitie examples
Proprietary & Confidential | 25-August-2021
18
Chromatography skid
19 Proprietary & Confidential | 25-August-2021
20 Proprietary & Confidential | 25-August-2021
Eppendorf incubators
WFI – Water For Injection
TruBio adaptation
Same control software throughout: TruBio Software
Data Integrity Maintained Through Tech Transfer
Scale: Commercial
Vessel size: Up to 5,000 L
Scale: Clinical
Vessel size: 30 L–2,000 L
Scale: Research/PD
Vessel size:1 L–50 L
Superior connectivity:
• Secure
• Repeatable
• Traceable
Proprietary & Confidential | 25-August-2021
21
The Data Flow
Data integrity and precise management to the top
Enterprise management level
(Planning, logistics, finance)
Plant management level
(Scheduling, analysis)
Production process control
(DCS, SCADA)
Plant floor equipment, control,
instrumentation, sensors, I/O
TruBio Software
Provides inherent connectivity
to DCS, consistent from R&D to production
Proprietary & Confidential | 25-August-2021
22
TruBio
23 Proprietary & Confidential | 25-August-2021
DreamReport
Provide Data
Generate and Execute
Design and Configure
Real-Time
Data and Alarms
HMIs, PLCs, DCS, SCADA, …
Connect to Data Sources
HISTORICAL DATA
• ODBC & OLE
• OPC HDA
• CSV files
• Native drivers for
proprietary archives
REAL TIME
Data and alarms
• OPC DA-AE
• Native Drivers
Dream Report logger can archive
real time data into any open
database
• SQL Server
• MySQL
• Oracle
• Access
• …
Provide Data
Provide Data
Provide Reports
• Design reports in easy environment
• Use Page Templates
• Use Report Templates
Define and periodically execute
any type of calculations:
Min, Max, Average, Current,
Integral, Duration, Counter, SQL
commands, free Mathematical
Calculation…
Automatically:
❑ On Schedule
❑ On Event
Manually:
❑ Select Report
❑ Change period or select batch
❑ Generate new report
Automatically Publish and Distribute
Generate
Reports
Design
Reports
Configure Data
Aggregation
Access existing
3rd-party archives
Data
Logger
Web Portal File Server Email Printers Mobile
FTP Server
Femi Egbebi, PhD
Multi-Omics for Cell Culture
Medium and Process
Development
Senior Global Product Manager
Proprietary & Confidential | 25-August-2021
24
Why multi-omics for medium and process development?
Untargeted towards targeted
25 Proprietary & Confidential | 25-August-2021
Why multi-omics for medium and process development?
Untargeted towards targeted
26 Proprietary & Confidential | 25-August-2021
Traditional vs. multi-omics media development workflow
27 Proprietary & Confidential | 25-August-2021
Traditional workflow: multiple full-factorial DOEs
< 50 molecules: amino acids, ~10 metabolites
Multi-omics workflow: metabolic pathway analysis
8000 molecules: 1000 metabolites, 7000 proteins
Tech
transfer
Media
mixture
DOE
Medium
optimization
DOE
Process
optimization
Non-GMP /
dry powder
Feed
optimization
DOE
Panel screening
(Metabolic baseline
establishment)
Multi-omics data
interrogation
(Acquisition, analysis,
interpretation)
Media & feed
design DOE
Media, feed &
process optimization
Non-GMP /
dry powder
Multi-omics provides more information, better insights into nutritional requirements
Titer
Titer
Introduction: multi-omics driven medium design
28 Proprietary & Confidential | 25-August-2021
Metabolic
Baseline
• Adapt to a panel of media
• Perform growth performance assay (GPA)
• Multi-omics sample collection
Multi-Omics
Analysis
• Automated sample preparation
• Sate-of-the-art multi-omics analysis
• Multi-Omics integration and interpretation
Omics
Driven DOE
• Identify pathways and networks influencing GPA features
• Design and validate DOE factors of interest in AMBR
• QC of mAbs and medium formulation
Biological function-oriented cell culture media development
Establishing a metabolic baseline
Characterizing the cell culture process and fed-batch media
➢ Robust and scalable: Pursues the small-scale
model; is relevant and predictive to the large-scale
process.
➢ Fed-batch cultivation: Utilizes run data from a
panel evolution to identify which conditions to analyze.
▪ Low VCD vs High VCD
▪ Low Titer vs High Titer
▪ Low Viability vs High Viability
➢ Spent media analysis: Metabolic run data
(Glucose, Lactate, Glutamine, Ammonia etc.) can guide
initial interpretation of Multi-Omics data sets.
➢ Quality attributes of mAbs: Glycosylation
pattern, charge variants, aggregates, and low-
molecular-weight species.
Media diversity & feature integration
Proprietary & Confidential | 25-August-2021
29
Multi-omics analysis workflow
Enable large-scale sample analysis and data interpretation
Analytical sensitivity/reproducibility & decision accuracy
Proprietary & Confidential | 25-August-2021
30
Small molecule identification & quantification
• Orbitrap ID-X Tribid MS system
• 3 mass analyzers: Quadrupole; LIT; Orbitrap
• Flexibility (Non-targeted & targeted assays)
• Tandem in time
• Quantification by Compound Discoverer
software
High accuracy, precision, resolution and sensitivity
Identify more endogenous metabolites
Proprietary & Confidential | 25-August-2021
31
Identification & quantification of large molecules
32
• Orbitrap Fusion Lumos Tribid MS
• Optimized HPLC-MS method
Identify / quantify more proteins in less time and with high reproducibility
Proprietary & Confidential | 20-Apr-2021
< 0.5 min RT shift across 100 runs < 20 % intensity drop across 100 runs
Case study: Application of multi-omics approach in the
development of a CHO production medium
33
Experimental approach
• Goal: Perform a proof-of-concept experiment to demonstrate the ability to design/improve cell
culture medium from multi-omics data sets
• Background:
• CHO-S cell line produces ~40% more IgG in Medium 1 vs. Medium 2
• Medium 1 and Medium 2 are chemically-defined CHO media
• Target:
• Improve Medium 2 to exceed Medium 1 performance by 50% using traditional and omics
approaches in parallel
Proprietary & Confidential | 25-August-2021
Case study: Application of multi-omics approach in the
development of a CHO production medium
IgG titer of CHO cell line in Medium 1 and Medium 2 in a simple fed-batch process in 1L bioreactor
CHO S cell line demonstrated 40% higher titer in Medium 1 as compared to Medium 2
Simple fed-batch
process sampled for
metabolomics (daily)
and proteomics
(arrows)
34 Proprietary & Confidential | 25-August-2021
Case study: Application of multi-omics approach in the
development of a CHO production medium
35
Mass spec omics analysis
Titer influencing pathway
identification
Omics guided DOE
Medium 2
Medium 1
Omics approach prototype
Traditional approach prototype
>1500
changes
7000 proteins + 1000 metabolites
identified
Pathways highlighted
Successfully met project goal utilizing omics approach in medium development
Proprietary & Confidential | 25-August-2021
Multi factorial DOE based on multi-omics analysis
36 Proprietary & Confidential | 25-August-2021
Titer improvement is impressive - competitive enough against other improvement options
Amonia Influencers TCA Intermediates Lactate Influencers Critical Amino Acids Anti-Oxidants
1 -1 1 -1 -1 -1
2 -1 -1 1 -1 -1
3 1 1 -1 1 -1
4 -1 -1 -1 -1 1
5 -1 -1 -1 1 -1
6 -1 1 -1 1 1
7 1 -1 1 -1 1
8 1 1 -1 -1 1
9 1 1 1 -1 -1
10 1 -1 -1 1 1
11 1 1 1 1 1
12 -1 1 1 1 -1
13 -1 -1 1 1 1
14 1 -1 1 1 -1
15 1 -1 -1 -1 -1
16 -1 1 1 -1 1
Final optimization resulted in a 3x increase in titer for customer
Why choose Thermo Fisher for media development?
37
Experience and expertise Collaborative
Driving performance through collaboration
• 50 years of cell line / media development
experience
• 150 projects completed since 2006
• Decades of tech transfer expertise
• Worked with >100 client PD groups
• 35% of projects from repeat customers
• Dedicated business team, support team
and program managers
Consistency
• World-class processes and facilities
• Assurance of supply to meet demands
• Scalability to GMP
• Rapid Prototyping Service
Proprietary & Confidential | 25-August-2021
Daniel Merriman
Real-time Monitoring of
Fermentation & Cell Culture
Senior Manager, Strategic Marketing
Proprietary & Confidential | 25-August-2021
38
What the FDA says about PAT
• PAT provides an opportunity to move from the current “testing to document quality” paradigm to a
“Continuous Quality Assurance” paradigm that can improve our ability to ensure quality was “built-in”
or was “by design” - ultimate realization of the true spirit of cGMP!
• Greater insight and understating of processes
• At/On/In-line measurement of “performance” attributes
• Real-time or rapid feedback controls (focus on prevention)
• Potential for significant reduction in production and development cycle time
• Minimize risks of poor process quality and reduce regulatory concerns
• Ajaz S. Hussain, Ph.D.
• Deputy Director, Office of Pharmaceutical Science, CDER, FDA
• ‘PAT Initiative: Next Steps’, 2004
Proprietary & Confidential | 25-August-2021
39
PAT steps
Source: Process Analytical Technologies for Pharmaceuticals: Global Markets. January 2018. bcc Research.
• Design phase: The critical quality
attributes (CQAs) influenced during
the process are studied and critical
process parameters (CPPs) are
determined
• Analysis phase: Analysis of the
appropriate CQAs studied in the first
phase
• Monitoring phase: monitor the CPPs
• Control phase: Controlling CPPs
based on understanding the process,
utilise real-time data, effect consistent
performance and product quality
PAT
Process
Design Analysis Monitor Control
Proprietary & Confidential | 25-August-2021
40
Implementation of gas analysis at the lab
Outlet Gas
DCS, PLC or
SCADA
Inlet Gas
Oxygen, Carbon Dioxide, Nitrogen, Argon
Outlet Gas
Oxygen, Carbon Dioxide, Nitrogen, Argon
Derived Values (RQ, CER, OUR)
Methanol, Ethanol, Water, Hydrogen, Ammonia, Hydrogen
Sulfide …
Prima BT
Inlet Gas
Vent
Proprietary & Confidential | 25-August-2021
41
The value of respiratory gas analysis
Oxygen Uptake Rate can be used to trigger nutrient additions to maintain viability
Glutamine depletion
Proprietary & Confidential | 25-August-2021
42
Bacterial & microbial fermentation
E. coli fed batch fermentation over 60 hours
MS measures O2, CO2, N2 & Ar in inlet and outlet and calculates RQ
Reagent introduced at temperature To
to induce cells to change from multiplying to
expressing desired product
S. cerevisiae fed batch fermentation over 60 hours
MS measures O2, CO2, EtOH, N2 & Ar in inlet and outlet and calculates RQ
Ethanol is initial carbon source, then switch over to glucose to achieve RQ of 1 and
desired product
Proprietary & Confidential | 25-August-2021
43
Process control by RQ – fed batch
Fed batch process with hexose carbon source
Aim to maintain RQ at 1
Nutrient is added in increments as fermentation progresses
When RQ drops to 0.8, add glucose and biomass continues to grow
Second & third triggers for glucose addition set at 0.85
This degree of control can only be provided with very precise RQ measurement
No other technique can match this level of precision
Proprietary & Confidential | 25-August-2021
44
Cell culture – early experiment (VCC and off-gas)
Significantly higher VCC in Bio 1 that Bio 2
Significantly more CO2 evolved and O2 consumed in Bio 1 than Bio 2
Changes in feed gas composition produce significant noise levels in feed
concentrations
Source: Applications of off-gas mass spectrometry in fed-batch mammalian cell culture. Goh Hai-Yuan et al., 2019
Proprietary & Confidential | 25-August-2021
45
Cell culture – later experiment (VCC and off gas)
Significantly higher VCC in Bio 1 that Bio 2
Significantly more CO2 evolved and O2 consumed in Bio 1 than Bio 2
Changes in feed gas composition produce significant noise levels in feed
concentrations
Source: Applications of off-gas mass spectrometry in fed-batch mammalian cell culture. Goh Hai-Yuan et al., 2019
Proprietary & Confidential | 25-August-2021
46
Sparge gas O2 and VCC correlation
Source: Applications of off-gas mass spectrometry in fed-batch mammalian cell culture. Goh Hai-Yuan et al., 2019
Proprietary & Confidential | 25-August-2021
47
RQ determination – cell culture
The GasWorks software can calculate and report automatically and in real-time
the Oxygen Uptake Rate (OUR) and Carbon Dioxide Evolution Rate (CER) in
terms of percentages of inlet flow (CDC and OXC), and also the Respiratory
Quotient (RQ).
CDC and OXC reached plateau just after 100 hours and
subsequently diverged suggesting a switch in cellular metabolism.
In the lag-phase, the RQ values obtained are not significant
as very little respiratory activity is occurring.
RQ values was between 1.0-0.8 during the logarithmic growth and
stationary phase stages, matching theoretical values of 0.9 based on
glutamine and glucose oxidation (Fitzpatrick et al., 1993).
Source: Online characterization of mammalian cell culture off-gas composition by magnetic sector MS for real-time bioprocess monitoring
Floris et al., 2020
Proprietary & Confidential | 25-August-2021
48
Types of biotech customers
Pharmaceuticals
Antibiotics, Proteins, Enzymes, Hormones, Vaccines,
Vitamins
Food Ingredients
Monosodium Glutamate, Riboflavin
Agricultural Products
•Plant Nutrients, Animal Food Supplements
Biomaterials
•Collagen, Biodegradable Plastics
Bio-fuels
•Ethanol, Propanol, Butanol, Hydrogen for Fuel Cells
Proprietary & Confidential | 25-August-2021
49
Resources
Web resources – video, specific PAT pages, e-books, product pages etc…
Proprietary & Confidential | 25-August-2021
50
51 Proprietary & Confidential | 25-August-2021
Thank you
Thank you for participating!
CLICK HERE to learn more and
watch the webinar
Daniel Merriman
Strategic Marketing Manager
Thermo Fisher Scientific
Femi Egbebi, PhD
Senior Global Product Manager
Media Development
Services/Omics Capabilities
Thermo Fisher Scientific
Krzysztof Inglot, PhD
Technical Sales Specialist
Thermo Fisher Scientific

Contenu connexe

Plus de InsideScientific

Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...InsideScientific
 
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...InsideScientific
 
Simple Tips to Significantly Improve Rodent Surgical Outcomes
 Simple Tips to Significantly Improve Rodent Surgical Outcomes Simple Tips to Significantly Improve Rodent Surgical Outcomes
Simple Tips to Significantly Improve Rodent Surgical OutcomesInsideScientific
 
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...InsideScientific
 
Creating Better Gene-Edited Cell Lines with the FAST-HDR System
Creating Better Gene-Edited Cell Lines with the FAST-HDR SystemCreating Better Gene-Edited Cell Lines with the FAST-HDR System
Creating Better Gene-Edited Cell Lines with the FAST-HDR SystemInsideScientific
 
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...InsideScientific
 
Designing Causal Inference Studies Using Real-World Data
Designing Causal Inference Studies Using Real-World DataDesigning Causal Inference Studies Using Real-World Data
Designing Causal Inference Studies Using Real-World DataInsideScientific
 
Social Media Data: Opportunities and Insights for Clinical Research
Social Media Data: Opportunities and Insights for Clinical ResearchSocial Media Data: Opportunities and Insights for Clinical Research
Social Media Data: Opportunities and Insights for Clinical ResearchInsideScientific
 
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...InsideScientific
 
Antibody Discovery by Single B Cell Screening on Beacon®
Antibody Discovery by Single B Cell Screening on Beacon®Antibody Discovery by Single B Cell Screening on Beacon®
Antibody Discovery by Single B Cell Screening on Beacon®InsideScientific
 
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...InsideScientific
 
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...InsideScientific
 
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...InsideScientific
 
Achieving Consensus When Everyone is an Expert, but No One Agrees
Achieving Consensus When Everyone is an Expert, but No One AgreesAchieving Consensus When Everyone is an Expert, but No One Agrees
Achieving Consensus When Everyone is an Expert, but No One AgreesInsideScientific
 
Investigating a Novel Regulator of Atrial Contractility
Investigating a Novel Regulator of Atrial ContractilityInvestigating a Novel Regulator of Atrial Contractility
Investigating a Novel Regulator of Atrial ContractilityInsideScientific
 
Cardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics
Cardiovascular Regenerative Medicine: Deconstructing Regenerative TherapeuticsCardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics
Cardiovascular Regenerative Medicine: Deconstructing Regenerative TherapeuticsInsideScientific
 
Cardiac Tissue Slices: Preparation, Data Acquisition, and Analysis
Cardiac Tissue Slices: Preparation, Data Acquisition, and AnalysisCardiac Tissue Slices: Preparation, Data Acquisition, and Analysis
Cardiac Tissue Slices: Preparation, Data Acquisition, and AnalysisInsideScientific
 
An Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease ModelingAn Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease ModelingInsideScientific
 
Inflammation and Vascular Damage in Hypertension
Inflammation and Vascular Damage in HypertensionInflammation and Vascular Damage in Hypertension
Inflammation and Vascular Damage in HypertensionInsideScientific
 
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...InsideScientific
 

Plus de InsideScientific (20)

Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...
 
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...
 
Simple Tips to Significantly Improve Rodent Surgical Outcomes
 Simple Tips to Significantly Improve Rodent Surgical Outcomes Simple Tips to Significantly Improve Rodent Surgical Outcomes
Simple Tips to Significantly Improve Rodent Surgical Outcomes
 
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...
 
Creating Better Gene-Edited Cell Lines with the FAST-HDR System
Creating Better Gene-Edited Cell Lines with the FAST-HDR SystemCreating Better Gene-Edited Cell Lines with the FAST-HDR System
Creating Better Gene-Edited Cell Lines with the FAST-HDR System
 
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...
 
Designing Causal Inference Studies Using Real-World Data
Designing Causal Inference Studies Using Real-World DataDesigning Causal Inference Studies Using Real-World Data
Designing Causal Inference Studies Using Real-World Data
 
Social Media Data: Opportunities and Insights for Clinical Research
Social Media Data: Opportunities and Insights for Clinical ResearchSocial Media Data: Opportunities and Insights for Clinical Research
Social Media Data: Opportunities and Insights for Clinical Research
 
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...
 
Antibody Discovery by Single B Cell Screening on Beacon®
Antibody Discovery by Single B Cell Screening on Beacon®Antibody Discovery by Single B Cell Screening on Beacon®
Antibody Discovery by Single B Cell Screening on Beacon®
 
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...
 
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...
 
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
 
Achieving Consensus When Everyone is an Expert, but No One Agrees
Achieving Consensus When Everyone is an Expert, but No One AgreesAchieving Consensus When Everyone is an Expert, but No One Agrees
Achieving Consensus When Everyone is an Expert, but No One Agrees
 
Investigating a Novel Regulator of Atrial Contractility
Investigating a Novel Regulator of Atrial ContractilityInvestigating a Novel Regulator of Atrial Contractility
Investigating a Novel Regulator of Atrial Contractility
 
Cardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics
Cardiovascular Regenerative Medicine: Deconstructing Regenerative TherapeuticsCardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics
Cardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics
 
Cardiac Tissue Slices: Preparation, Data Acquisition, and Analysis
Cardiac Tissue Slices: Preparation, Data Acquisition, and AnalysisCardiac Tissue Slices: Preparation, Data Acquisition, and Analysis
Cardiac Tissue Slices: Preparation, Data Acquisition, and Analysis
 
An Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease ModelingAn Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease Modeling
 
Inflammation and Vascular Damage in Hypertension
Inflammation and Vascular Damage in HypertensionInflammation and Vascular Damage in Hypertension
Inflammation and Vascular Damage in Hypertension
 
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
 

Dernier

The dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxThe dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxEran Akiva Sinbar
 
Harmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms PresentationHarmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms Presentationtahreemzahra82
 
Four Spheres of the Earth Presentation.ppt
Four Spheres of the Earth Presentation.pptFour Spheres of the Earth Presentation.ppt
Four Spheres of the Earth Presentation.pptJoemSTuliba
 
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...lizamodels9
 
Topic 9- General Principles of International Law.pptx
Topic 9- General Principles of International Law.pptxTopic 9- General Principles of International Law.pptx
Topic 9- General Principles of International Law.pptxJorenAcuavera1
 
Neurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trNeurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trssuser06f238
 
Speech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxSpeech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxpriyankatabhane
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝soniya singh
 
Davis plaque method.pptx recombinant DNA technology
Davis plaque method.pptx recombinant DNA technologyDavis plaque method.pptx recombinant DNA technology
Davis plaque method.pptx recombinant DNA technologycaarthichand2003
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfSELF-EXPLANATORY
 
Base editing, prime editing, Cas13 & RNA editing and organelle base editing
Base editing, prime editing, Cas13 & RNA editing and organelle base editingBase editing, prime editing, Cas13 & RNA editing and organelle base editing
Base editing, prime editing, Cas13 & RNA editing and organelle base editingNetHelix
 
Carbon Dioxide Capture and Storage (CSS)
Carbon Dioxide Capture and Storage (CSS)Carbon Dioxide Capture and Storage (CSS)
Carbon Dioxide Capture and Storage (CSS)Tamer Koksalan, PhD
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPirithiRaju
 
FREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naFREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naJASISJULIANOELYNV
 
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxMicrophone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxpriyankatabhane
 
Vision and reflection on Mining Software Repositories research in 2024
Vision and reflection on Mining Software Repositories research in 2024Vision and reflection on Mining Software Repositories research in 2024
Vision and reflection on Mining Software Repositories research in 2024AyushiRastogi48
 
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.PraveenaKalaiselvan1
 
Bioteknologi kelas 10 kumer smapsa .pptx
Bioteknologi kelas 10 kumer smapsa .pptxBioteknologi kelas 10 kumer smapsa .pptx
Bioteknologi kelas 10 kumer smapsa .pptx023NiWayanAnggiSriWa
 
《Queensland毕业文凭-昆士兰大学毕业证成绩单》
《Queensland毕业文凭-昆士兰大学毕业证成绩单》《Queensland毕业文凭-昆士兰大学毕业证成绩单》
《Queensland毕业文凭-昆士兰大学毕业证成绩单》rnrncn29
 
Fertilization: Sperm and the egg—collectively called the gametes—fuse togethe...
Fertilization: Sperm and the egg—collectively called the gametes—fuse togethe...Fertilization: Sperm and the egg—collectively called the gametes—fuse togethe...
Fertilization: Sperm and the egg—collectively called the gametes—fuse togethe...D. B. S. College Kanpur
 

Dernier (20)

The dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxThe dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptx
 
Harmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms PresentationHarmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms Presentation
 
Four Spheres of the Earth Presentation.ppt
Four Spheres of the Earth Presentation.pptFour Spheres of the Earth Presentation.ppt
Four Spheres of the Earth Presentation.ppt
 
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
 
Topic 9- General Principles of International Law.pptx
Topic 9- General Principles of International Law.pptxTopic 9- General Principles of International Law.pptx
Topic 9- General Principles of International Law.pptx
 
Neurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trNeurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 tr
 
Speech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxSpeech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptx
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
 
Davis plaque method.pptx recombinant DNA technology
Davis plaque method.pptx recombinant DNA technologyDavis plaque method.pptx recombinant DNA technology
Davis plaque method.pptx recombinant DNA technology
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
 
Base editing, prime editing, Cas13 & RNA editing and organelle base editing
Base editing, prime editing, Cas13 & RNA editing and organelle base editingBase editing, prime editing, Cas13 & RNA editing and organelle base editing
Base editing, prime editing, Cas13 & RNA editing and organelle base editing
 
Carbon Dioxide Capture and Storage (CSS)
Carbon Dioxide Capture and Storage (CSS)Carbon Dioxide Capture and Storage (CSS)
Carbon Dioxide Capture and Storage (CSS)
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
 
FREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naFREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by na
 
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxMicrophone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
 
Vision and reflection on Mining Software Repositories research in 2024
Vision and reflection on Mining Software Repositories research in 2024Vision and reflection on Mining Software Repositories research in 2024
Vision and reflection on Mining Software Repositories research in 2024
 
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
 
Bioteknologi kelas 10 kumer smapsa .pptx
Bioteknologi kelas 10 kumer smapsa .pptxBioteknologi kelas 10 kumer smapsa .pptx
Bioteknologi kelas 10 kumer smapsa .pptx
 
《Queensland毕业文凭-昆士兰大学毕业证成绩单》
《Queensland毕业文凭-昆士兰大学毕业证成绩单》《Queensland毕业文凭-昆士兰大学毕业证成绩单》
《Queensland毕业文凭-昆士兰大学毕业证成绩单》
 
Fertilization: Sperm and the egg—collectively called the gametes—fuse togethe...
Fertilization: Sperm and the egg—collectively called the gametes—fuse togethe...Fertilization: Sperm and the egg—collectively called the gametes—fuse togethe...
Fertilization: Sperm and the egg—collectively called the gametes—fuse togethe...
 

Streamlining Process Monitoring in Cell Culture Analysis & Spectrometry

  • 1. Streamlining Process Monitoring in Cell Culture Analysis & Spectrometry Daniel Merriman Strategic Marketing Manager Thermo Fisher Scientific Femi Egbebi, PhD Senior Global Product Manager Media Development Services/Omics Capabilities Thermo Fisher Scientific Krzysztof Inglot, PhD Technical Sales Specialist Thermo Fisher Scientific
  • 2. Application and technical experts present an overview of process monitoring systems in the biopharma field. Streamlining Process Monitoring in Cell Culture Analysis & Spectrometry
  • 3. Krzysztof Inglot, PhD Streamlining Process Monitoring with TruBio SUT Technical Sales Specialist, CEE & Middle East Proprietary & Confidential | 25-August-2021 3
  • 4. Quality Scale-Up is Critical • Time to market • Manual data entry What are the challenges? What is most critical? • Consistent/predictable product quality • System validation • Data integrity • GMP manufacturing facility regulatory requirements • Risk mitigation • Speed to market • Efficient, traceable data transfer • Quality of data maintained throughout the manufacturing process Proprietary & Confidential | 25-August-2021 4
  • 5. Industry Challenge • Integration of existing equipment causing automation islands • Highly engineered, product-specific PLC based facilities • Unique and nonstandard data output Facility flexibility Mobius CellReady EMD Millipore BioBLU Eppendorf UniVessel Glass Sartorius ez2-Control Applikon Allegro STR Pall Xcellerex XDR GE Life Sciences Xcellerex XDR 10 GE Life Sciences BIOSTAT STR Sartorius HyPerforma S.U.B. Thermo Fisher Scientific Mobius Single-Use Bioreactor EMD Millipore Proprietary & Confidential | 25-August-2021 5
  • 6. Our Solution A highly configurable, open-architecture system from R&D to production TruBio Software Research/PD Clinical to production Proprietary & Confidential | 25-August-2021 6
  • 7. Our Solution One consistent solution from R&D to production Thermo Scientific™ TruBio™ Software Clinical Production TruBio Software DCS/SCADA consistent data flow Research & Process Development Proprietary & Confidential | 25-August-2021 7
  • 8. DeltaV Network Remote Access Redundant DeltaV Network Plant LAN Operator Station Professional Plus Application Station/Historian Scales, pumps, G3Lab Universal Controller for Small Scale Vessels OPC SERVER Plant Messenger OPC compliant third party bioreactor controllers, Analyzers or other devices G3Pro Universal controller for highest vessel flexibility as single or dual systems G3Lite controller for one vessel Terminal Server DeltaV Controller Centrifugation Mixers Clarification Chromatography Virus Removal Ultrafiltration Sterile filtration Filtration OPC OPC Operator Station PCs or mobile devices with browser (TS) Proprietary & Confidential | 25-August-2021 8
  • 9. Introduction to TruBio 9 Proprietary & Confidential | 25-August-2021 • Software application with inbuilt control strategies specifically for bioprocesses. • Commercial off the shelf (COTS), FDA 21 CFR part 11 compliant. • Easy to plan, modify and implement new process requirements using the standard TruBio functions and features. • Based on Emerson’s DeltaV with easy scale- up and -down between R&D, PD and manufacturing. • TruBio 5.0 requires DeltaV 12.3 or higher What is TruBio?
  • 10. Introduction to TruBio 10 Proprietary & Confidential | 25-August-2021 What are Control Strategies • Control Strategies are a predefined function which assist the operators achieve their process requirements. • TruBio contains the following functions as standard (e.g.): • pH Control • DO (Dissolved Oxygen) Control • Temperature Control • Weight Control • Dosing • Continuous • pH Base and pH Acid • Pump Totals • Multi Feed Dosing • The following functions come as standard in TruBio to assist in easy setup and process manipulation: • Calibration of IO and calibration records (e.g. pH, DO, pumps) • Save/load files: easy exchanging control strategies between sites • Vessel selection – Move from one vessel independent of size to another. • Use the same IO tower for running different vessels. TruBio Functions
  • 11. TruBio and Vessel Integration 11 Proprietary & Confidential | 25-August-2021
  • 12. TruBio 12 Proprietary & Confidential | 25-August-2021 TruBio and Vessel Integration • Seamless integration with other manufacture vessels and rockers e.g. • Integration with other manufacture equipment e.g..
  • 13. TruBio 13 Proprietary & Confidential | 25-August-2021 TruBio Third-party interfacing examples TRUBIO DeltaV system Eppendorf Incubators GE Chrom Skids Parker NFF Skids Parker TFF Skids Satorius Scales Hamilton Probes Various Manufacture TCUs Remote IO Panels Profibus Modbus Ethernet IP Traditional IO OPC OPC OPC Modbus Traditional IO/ Modbus/ Profibus
  • 14. Standard TruBio – Process Configuration without Programming Proprietary & Confidential | 25-August-2021 14
  • 15. TruBio 5.0 + G3Lab Universal controller ≤ 250L HyPerforma Glass Bioreactor HyPerforma Rocker Benchtop Single-Use Bioreactor HyPerforma SUB Proprietary & Confidential | 25-August-2021 15
  • 16. Customized TruBio – Mapping the Process Proprietary & Confidential | 25-August-2021 16
  • 17. Customized TruBio – Mapping the Process Proprietary & Confidential | 25-August-2021 17
  • 18. Facilitie examples Proprietary & Confidential | 25-August-2021 18
  • 19. Chromatography skid 19 Proprietary & Confidential | 25-August-2021
  • 20. 20 Proprietary & Confidential | 25-August-2021 Eppendorf incubators WFI – Water For Injection TruBio adaptation
  • 21. Same control software throughout: TruBio Software Data Integrity Maintained Through Tech Transfer Scale: Commercial Vessel size: Up to 5,000 L Scale: Clinical Vessel size: 30 L–2,000 L Scale: Research/PD Vessel size:1 L–50 L Superior connectivity: • Secure • Repeatable • Traceable Proprietary & Confidential | 25-August-2021 21
  • 22. The Data Flow Data integrity and precise management to the top Enterprise management level (Planning, logistics, finance) Plant management level (Scheduling, analysis) Production process control (DCS, SCADA) Plant floor equipment, control, instrumentation, sensors, I/O TruBio Software Provides inherent connectivity to DCS, consistent from R&D to production Proprietary & Confidential | 25-August-2021 22
  • 23. TruBio 23 Proprietary & Confidential | 25-August-2021 DreamReport Provide Data Generate and Execute Design and Configure Real-Time Data and Alarms HMIs, PLCs, DCS, SCADA, … Connect to Data Sources HISTORICAL DATA • ODBC & OLE • OPC HDA • CSV files • Native drivers for proprietary archives REAL TIME Data and alarms • OPC DA-AE • Native Drivers Dream Report logger can archive real time data into any open database • SQL Server • MySQL • Oracle • Access • … Provide Data Provide Data Provide Reports • Design reports in easy environment • Use Page Templates • Use Report Templates Define and periodically execute any type of calculations: Min, Max, Average, Current, Integral, Duration, Counter, SQL commands, free Mathematical Calculation… Automatically: ❑ On Schedule ❑ On Event Manually: ❑ Select Report ❑ Change period or select batch ❑ Generate new report Automatically Publish and Distribute Generate Reports Design Reports Configure Data Aggregation Access existing 3rd-party archives Data Logger Web Portal File Server Email Printers Mobile FTP Server
  • 24. Femi Egbebi, PhD Multi-Omics for Cell Culture Medium and Process Development Senior Global Product Manager Proprietary & Confidential | 25-August-2021 24
  • 25. Why multi-omics for medium and process development? Untargeted towards targeted 25 Proprietary & Confidential | 25-August-2021
  • 26. Why multi-omics for medium and process development? Untargeted towards targeted 26 Proprietary & Confidential | 25-August-2021
  • 27. Traditional vs. multi-omics media development workflow 27 Proprietary & Confidential | 25-August-2021 Traditional workflow: multiple full-factorial DOEs < 50 molecules: amino acids, ~10 metabolites Multi-omics workflow: metabolic pathway analysis 8000 molecules: 1000 metabolites, 7000 proteins Tech transfer Media mixture DOE Medium optimization DOE Process optimization Non-GMP / dry powder Feed optimization DOE Panel screening (Metabolic baseline establishment) Multi-omics data interrogation (Acquisition, analysis, interpretation) Media & feed design DOE Media, feed & process optimization Non-GMP / dry powder Multi-omics provides more information, better insights into nutritional requirements Titer Titer
  • 28. Introduction: multi-omics driven medium design 28 Proprietary & Confidential | 25-August-2021 Metabolic Baseline • Adapt to a panel of media • Perform growth performance assay (GPA) • Multi-omics sample collection Multi-Omics Analysis • Automated sample preparation • Sate-of-the-art multi-omics analysis • Multi-Omics integration and interpretation Omics Driven DOE • Identify pathways and networks influencing GPA features • Design and validate DOE factors of interest in AMBR • QC of mAbs and medium formulation Biological function-oriented cell culture media development
  • 29. Establishing a metabolic baseline Characterizing the cell culture process and fed-batch media ➢ Robust and scalable: Pursues the small-scale model; is relevant and predictive to the large-scale process. ➢ Fed-batch cultivation: Utilizes run data from a panel evolution to identify which conditions to analyze. ▪ Low VCD vs High VCD ▪ Low Titer vs High Titer ▪ Low Viability vs High Viability ➢ Spent media analysis: Metabolic run data (Glucose, Lactate, Glutamine, Ammonia etc.) can guide initial interpretation of Multi-Omics data sets. ➢ Quality attributes of mAbs: Glycosylation pattern, charge variants, aggregates, and low- molecular-weight species. Media diversity & feature integration Proprietary & Confidential | 25-August-2021 29
  • 30. Multi-omics analysis workflow Enable large-scale sample analysis and data interpretation Analytical sensitivity/reproducibility & decision accuracy Proprietary & Confidential | 25-August-2021 30
  • 31. Small molecule identification & quantification • Orbitrap ID-X Tribid MS system • 3 mass analyzers: Quadrupole; LIT; Orbitrap • Flexibility (Non-targeted & targeted assays) • Tandem in time • Quantification by Compound Discoverer software High accuracy, precision, resolution and sensitivity Identify more endogenous metabolites Proprietary & Confidential | 25-August-2021 31
  • 32. Identification & quantification of large molecules 32 • Orbitrap Fusion Lumos Tribid MS • Optimized HPLC-MS method Identify / quantify more proteins in less time and with high reproducibility Proprietary & Confidential | 20-Apr-2021 < 0.5 min RT shift across 100 runs < 20 % intensity drop across 100 runs
  • 33. Case study: Application of multi-omics approach in the development of a CHO production medium 33 Experimental approach • Goal: Perform a proof-of-concept experiment to demonstrate the ability to design/improve cell culture medium from multi-omics data sets • Background: • CHO-S cell line produces ~40% more IgG in Medium 1 vs. Medium 2 • Medium 1 and Medium 2 are chemically-defined CHO media • Target: • Improve Medium 2 to exceed Medium 1 performance by 50% using traditional and omics approaches in parallel Proprietary & Confidential | 25-August-2021
  • 34. Case study: Application of multi-omics approach in the development of a CHO production medium IgG titer of CHO cell line in Medium 1 and Medium 2 in a simple fed-batch process in 1L bioreactor CHO S cell line demonstrated 40% higher titer in Medium 1 as compared to Medium 2 Simple fed-batch process sampled for metabolomics (daily) and proteomics (arrows) 34 Proprietary & Confidential | 25-August-2021
  • 35. Case study: Application of multi-omics approach in the development of a CHO production medium 35 Mass spec omics analysis Titer influencing pathway identification Omics guided DOE Medium 2 Medium 1 Omics approach prototype Traditional approach prototype >1500 changes 7000 proteins + 1000 metabolites identified Pathways highlighted Successfully met project goal utilizing omics approach in medium development Proprietary & Confidential | 25-August-2021
  • 36. Multi factorial DOE based on multi-omics analysis 36 Proprietary & Confidential | 25-August-2021 Titer improvement is impressive - competitive enough against other improvement options Amonia Influencers TCA Intermediates Lactate Influencers Critical Amino Acids Anti-Oxidants 1 -1 1 -1 -1 -1 2 -1 -1 1 -1 -1 3 1 1 -1 1 -1 4 -1 -1 -1 -1 1 5 -1 -1 -1 1 -1 6 -1 1 -1 1 1 7 1 -1 1 -1 1 8 1 1 -1 -1 1 9 1 1 1 -1 -1 10 1 -1 -1 1 1 11 1 1 1 1 1 12 -1 1 1 1 -1 13 -1 -1 1 1 1 14 1 -1 1 1 -1 15 1 -1 -1 -1 -1 16 -1 1 1 -1 1 Final optimization resulted in a 3x increase in titer for customer
  • 37. Why choose Thermo Fisher for media development? 37 Experience and expertise Collaborative Driving performance through collaboration • 50 years of cell line / media development experience • 150 projects completed since 2006 • Decades of tech transfer expertise • Worked with >100 client PD groups • 35% of projects from repeat customers • Dedicated business team, support team and program managers Consistency • World-class processes and facilities • Assurance of supply to meet demands • Scalability to GMP • Rapid Prototyping Service Proprietary & Confidential | 25-August-2021
  • 38. Daniel Merriman Real-time Monitoring of Fermentation & Cell Culture Senior Manager, Strategic Marketing Proprietary & Confidential | 25-August-2021 38
  • 39. What the FDA says about PAT • PAT provides an opportunity to move from the current “testing to document quality” paradigm to a “Continuous Quality Assurance” paradigm that can improve our ability to ensure quality was “built-in” or was “by design” - ultimate realization of the true spirit of cGMP! • Greater insight and understating of processes • At/On/In-line measurement of “performance” attributes • Real-time or rapid feedback controls (focus on prevention) • Potential for significant reduction in production and development cycle time • Minimize risks of poor process quality and reduce regulatory concerns • Ajaz S. Hussain, Ph.D. • Deputy Director, Office of Pharmaceutical Science, CDER, FDA • ‘PAT Initiative: Next Steps’, 2004 Proprietary & Confidential | 25-August-2021 39
  • 40. PAT steps Source: Process Analytical Technologies for Pharmaceuticals: Global Markets. January 2018. bcc Research. • Design phase: The critical quality attributes (CQAs) influenced during the process are studied and critical process parameters (CPPs) are determined • Analysis phase: Analysis of the appropriate CQAs studied in the first phase • Monitoring phase: monitor the CPPs • Control phase: Controlling CPPs based on understanding the process, utilise real-time data, effect consistent performance and product quality PAT Process Design Analysis Monitor Control Proprietary & Confidential | 25-August-2021 40
  • 41. Implementation of gas analysis at the lab Outlet Gas DCS, PLC or SCADA Inlet Gas Oxygen, Carbon Dioxide, Nitrogen, Argon Outlet Gas Oxygen, Carbon Dioxide, Nitrogen, Argon Derived Values (RQ, CER, OUR) Methanol, Ethanol, Water, Hydrogen, Ammonia, Hydrogen Sulfide … Prima BT Inlet Gas Vent Proprietary & Confidential | 25-August-2021 41
  • 42. The value of respiratory gas analysis Oxygen Uptake Rate can be used to trigger nutrient additions to maintain viability Glutamine depletion Proprietary & Confidential | 25-August-2021 42
  • 43. Bacterial & microbial fermentation E. coli fed batch fermentation over 60 hours MS measures O2, CO2, N2 & Ar in inlet and outlet and calculates RQ Reagent introduced at temperature To to induce cells to change from multiplying to expressing desired product S. cerevisiae fed batch fermentation over 60 hours MS measures O2, CO2, EtOH, N2 & Ar in inlet and outlet and calculates RQ Ethanol is initial carbon source, then switch over to glucose to achieve RQ of 1 and desired product Proprietary & Confidential | 25-August-2021 43
  • 44. Process control by RQ – fed batch Fed batch process with hexose carbon source Aim to maintain RQ at 1 Nutrient is added in increments as fermentation progresses When RQ drops to 0.8, add glucose and biomass continues to grow Second & third triggers for glucose addition set at 0.85 This degree of control can only be provided with very precise RQ measurement No other technique can match this level of precision Proprietary & Confidential | 25-August-2021 44
  • 45. Cell culture – early experiment (VCC and off-gas) Significantly higher VCC in Bio 1 that Bio 2 Significantly more CO2 evolved and O2 consumed in Bio 1 than Bio 2 Changes in feed gas composition produce significant noise levels in feed concentrations Source: Applications of off-gas mass spectrometry in fed-batch mammalian cell culture. Goh Hai-Yuan et al., 2019 Proprietary & Confidential | 25-August-2021 45
  • 46. Cell culture – later experiment (VCC and off gas) Significantly higher VCC in Bio 1 that Bio 2 Significantly more CO2 evolved and O2 consumed in Bio 1 than Bio 2 Changes in feed gas composition produce significant noise levels in feed concentrations Source: Applications of off-gas mass spectrometry in fed-batch mammalian cell culture. Goh Hai-Yuan et al., 2019 Proprietary & Confidential | 25-August-2021 46
  • 47. Sparge gas O2 and VCC correlation Source: Applications of off-gas mass spectrometry in fed-batch mammalian cell culture. Goh Hai-Yuan et al., 2019 Proprietary & Confidential | 25-August-2021 47
  • 48. RQ determination – cell culture The GasWorks software can calculate and report automatically and in real-time the Oxygen Uptake Rate (OUR) and Carbon Dioxide Evolution Rate (CER) in terms of percentages of inlet flow (CDC and OXC), and also the Respiratory Quotient (RQ). CDC and OXC reached plateau just after 100 hours and subsequently diverged suggesting a switch in cellular metabolism. In the lag-phase, the RQ values obtained are not significant as very little respiratory activity is occurring. RQ values was between 1.0-0.8 during the logarithmic growth and stationary phase stages, matching theoretical values of 0.9 based on glutamine and glucose oxidation (Fitzpatrick et al., 1993). Source: Online characterization of mammalian cell culture off-gas composition by magnetic sector MS for real-time bioprocess monitoring Floris et al., 2020 Proprietary & Confidential | 25-August-2021 48
  • 49. Types of biotech customers Pharmaceuticals Antibiotics, Proteins, Enzymes, Hormones, Vaccines, Vitamins Food Ingredients Monosodium Glutamate, Riboflavin Agricultural Products •Plant Nutrients, Animal Food Supplements Biomaterials •Collagen, Biodegradable Plastics Bio-fuels •Ethanol, Propanol, Butanol, Hydrogen for Fuel Cells Proprietary & Confidential | 25-August-2021 49
  • 50. Resources Web resources – video, specific PAT pages, e-books, product pages etc… Proprietary & Confidential | 25-August-2021 50
  • 51. 51 Proprietary & Confidential | 25-August-2021 Thank you
  • 52. Thank you for participating! CLICK HERE to learn more and watch the webinar Daniel Merriman Strategic Marketing Manager Thermo Fisher Scientific Femi Egbebi, PhD Senior Global Product Manager Media Development Services/Omics Capabilities Thermo Fisher Scientific Krzysztof Inglot, PhD Technical Sales Specialist Thermo Fisher Scientific